BBH ETF
VanEck Biotech ETF
BBH ETF Overview
BBH ETF (VanEck Biotech ETF) is managed by VanEck with $493.4M in net assets. BBH expense ratio is 0.35%, holding 50 positions across sectors including Health Care, Information Technology. Inception date: 2011-12-20.
BBH performance shows a YTD return of 24.89%. The 1-year return is 43.74% and the 5-year return is 2.71%. BBH dividend yield stands at 0.40%, paid annually.
BBH top holdings include Amgen Inc. (14.1%), Gilead Sciences (12.9%), Nvaesrtex Pharmaceuticals Inc (8.4%), Regeneron Pharmaceuticals, Inc. (6.9%), Moderna therapeutics (6.1%). Go to all BBH holdings, BBH sectors, or BBH dividends.
BBH can be compared against other funds. Use BBH overlap to find shared positions, or BBH vs another fund for a side-by-side view. BBH alternatives are available via the screener, along with tax-loss harvesting opportunities.